from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1294/thrA

LFCtreatmentdescriptionclass of inhibitor

-2.500

Amikacinug/mL Amikacintranslation

-1.614

Cap5-10ug/mL Capreomycintranslation

-2.428

Rox10-50 ug/mL Roxithromycintranslation

-0.737

SM2-5 ug/mL Streptomycintranslation

-4.140

Tet5-10 ug/mL Tetracyclinetranslation

-1.553

Rif0.2-5ug/mL Rifampicintranscription

-0.297

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.205

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.512

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.606

CPZ10-50 ug/mL Chlorpromazinerespiration

0.192

Clofazimine10-13 ug/mL Clofaziminerespiration

0.492

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.447

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.135

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.512

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.327

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.062

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.027

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.349

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.053

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.597

KCN5-20 ug/mL Potassium cyaniderespiration

0.898

NaN30.2-2 mM Sodium aziderespiration

-0.026

Nigericin50 uM Nigericinrespiration

-1.003

TRC10-150 ug/mL Triclosanrespiration

0.435

TRZ10-25 ug/mL Thioridazinerespiration

0.894

Valinomycin0.5-10 uM Valinomycinrespiration

0.476

ZnSO42 mM ZnSO4respiration

0.286

menadione6-10 ug/mL Menadionerespiration

-0.084

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.135

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.176

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.100

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.129

NRP_1Non-replicating persistence stage 1dosRassociated

0.081

Amp0.2mg/mL AmpicillincellWall

-0.011

Cephalexin20-100 ug/mL CephalexincellWall

0.342

Cerulenin0.32-5 ug/mL CerulenincellWall

0.020

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.414

EMB10-20 ug/mL EthambutolcellWall

0.032

Eta12-40 ug/mL EthionamidecellWall

0.640

INH0.2-0.4 ug/mL IsoniazidcellWall

0.173

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.587

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.090

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.832

BZA0.12 mg/mL BenzamidearomaticAmides

-0.170

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.022

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.104

H2O24 mM hydrogen peroxideDNAdamaging

0.315

Levo10 ug/mL LevofloxacinDNAdamaging

0.521

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

3.589

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.175

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.505

UVUV-irradiationDNAdamaging

-0.652

ARP41-4 ug/mL Antitubercular compound ARP4?

0.044

Antimycin12.5-50 ug/mL Antimycin A?

-0.076

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.516

PA_110-50 ug/mL Antitubercular compound PA-1?

0.158

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.153

PA8240.2-2 ug/mL PA-824?

0.468

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.490

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.216

Verapamil50 uM Verapamil?

-0.180

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.279

methoxatin10-20 ug/mL Methoxatin?